OraSure Technologies (OSUR)
(Delayed Data from NSDQ)
$4.35 USD
+0.04 (0.93%)
Updated Sep 19, 2024 04:00 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Company Summary
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Company Summary
General Information
OraSure Technologies, Inc
220 EAST FIRST STREET
BETHLEHEM, PA 18015
Phone: 610-882-1820
Fax: 610-882-1830
Email: investorinfo@orasure.com
Industry | Medical - Products |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/5/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.04 |
Current Year EPS Consensus Estimate | 0.05 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 11/5/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 4.31 |
52 Week High | 8.45 |
52 Week Low | 3.92 |
Beta | 0.05 |
20 Day Moving Average | 747,812.12 |
Target Price Consensus | 6.00 |
4 Week | 2.84 |
12 Week | 3.08 |
YTD | -46.95 |
4 Week | 0.26 |
12 Week | -1.08 |
YTD | -55.71 |
Shares Outstanding (millions) | 74.57 |
Market Capitalization (millions) | 324.37 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 93.21 |
Trailing 12 Months | 7.25 |
PEG Ratio | NA |
vs. Previous Year | 142.86% |
vs. Previous Quarter | NA |
vs. Previous Year | -36.41% |
vs. Previous Quarter | 0.38% |
Price/Book | 0.76 |
Price/Cash Flow | 3.24 |
Price / Sales | 1.19 |
6/30/24 | 9.15 |
3/31/24 | 7.68 |
12/31/23 | 14.50 |
6/30/24 | 8.24 |
3/31/24 | 6.83 |
12/31/23 | 12.69 |
6/30/24 | 12.17 |
3/31/24 | 11.97 |
12/31/23 | 9.77 |
6/30/24 | 10.84 |
3/31/24 | 10.49 |
12/31/23 | 8.57 |
6/30/24 | 14.12 |
3/31/24 | 10.44 |
12/31/23 | 14.51 |
6/30/24 | 9.88 |
3/31/24 | 7.50 |
12/31/23 | 13.23 |
6/30/24 | 11.31 |
3/31/24 | 8.42 |
12/31/23 | 13.88 |
6/30/24 | 5.76 |
3/31/24 | 5.57 |
12/31/23 | 5.86 |
6/30/24 | 3.09 |
3/31/24 | 3.13 |
12/31/23 | 3.63 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |
6/30/24 | 0.06 |
3/31/24 | 0.05 |
12/31/23 | 0.05 |